Quantification and kinetic analysis of Grb2-EGFR interaction on micro-patterned surfaces for the characterization of EGFR-modulating substances

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Lanzerstorfer, Peter ^a   Borgmann, Daniela ^b   Schütz, Gerhard ^c   Winkler, Stephan M ^b   Höglinger, Otmar ^a   Weghuber, Julian ^a  

^a UNIVERSITY OF APPLIED SCIENCES UPPER AUSTRIA   (Austria)

^b UNIVERSITY OF APPLIED SCIENCES UPPER AUSTRIA   (Austria)

^c VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE KINASE RECEPTOR; VASCULOTROPIN RECEPTOR; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; QUINAZOLINE DERIVATIVE; TYRPHOSTIN;

ARTICLE; BINDING SITE; CYTOTOXICITY; FLUORESCENCE MICROSCOPY; KINETICS; LIMIT OF QUANTITATION; MOLECULAR MECHANICS; MORPHOGENESIS; PREDATOR PREY INTERACTION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; ANTAGONISTS AND INHIBITORS; COATED PIT; HELA CELL LINE; HUMAN; METABOLISM; PROCEDURES;

COATED PITS, CELL-MEMBRANE; EPIDERMAL GROWTH FACTOR; GRB2 ADAPTOR PROTEIN; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TYRPHOSTINS;

EID: 84899126115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092151     Document Type: Article

References (47)

1. Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, et al. (2002) Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 110: 763-773. (Pubitemid 35283965)
2. Hubbard SR, Miller WT (2007) Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol 19: 117-123. (Pubitemid 46386407)
3. Bublil EM, Yarden Y (2007) The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol 19: 124-134. (Pubitemid 46386405)
4. Grewal T, Enrich C (2009) Annexins-modulators of EGF receptor signalling and trafficking. Cell Signal 21: 847-858.
5. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, et al. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2-16. (Pubitemid 43199589)
6. Walker F, Abramowitz L, Benabderrahmane D, Duval X, Descatoire V, et al. (2009) Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. Hum Pathol 40: 1517-1527.
7. Kuan CT, Wikstrand CJ, Bigner DD (2001) EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr Relat Cancer 8: 83-96. (Pubitemid 32641351)
8. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139. (Pubitemid 38637993)
9. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, et al. (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117: 2051-2058. (Pubitemid 47224766)
10. Sequist LV, Lynch TJ (2008) EGFR tyrosine kinase inhibitors in lung cancer: an evolving story. Annu Rev Med 59: 429-442. (Pubitemid 351287947)
11. Thomas SM, Grandis JR (2004) Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Cancer Treat Rev 30: 255-268. (Pubitemid 38477271)
12. Wheeler DL, Dunn EF, Harari PM (2010) Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7: 493-507.
13. Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341-354. (Pubitemid 40637826)
14. Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB (2010) Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods 7: 148-155.
15. Grecco HE, Roda-Navarro P, Girod A, Hou J, Frahm T, et al. (2010) In situ analysis of tyrosine phosphorylation networks by FLIM on cell arrays. Nat Methods 7: 467-472.
16. Olive DM (2004) Quantitative methods for the analysis of protein phosphorylation in drug development. Expert Rev Proteomics 1: 327-341.
17. Pennucci J, Swanson S, Kaliyaperumal A, Gupta S (2010) Multiplexed evaluation of a cell-based assay for the detection of antidrug neutralizing antibodies to panitumumab in human serum using automated fluorescent microscopy. J Biomol Screen 15: 644-652.
18. Antczak C, Bermingham A, Calder P, Malkov D, Song K, et al. (2012) Domain-based biosensor assay to screen for epidermal growth factor receptor modulators in live cells. Assay Drug Dev Technol 10: 24-36.
19. Alexander RA, Prager GW, Mihaly-Bison J, Uhrin P, Sunzenauer S, et al. (2012) VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution. Cardiovasc Res 94: 125-135.
20. Lanzerstorfer P, Borgmann D, Steininger A, Schaller S, Brameshuber M, et al. (2013) Analysis of Protein-Protein Interactions in Live Cells - The m-Patterning Approach. Protein Purification and Analysis - Methods and Applications. iConcept Press.
21. Schwarzenbacher M, Kaltenbrunner M, Brameshuber M, Hesch C, Paster W, et al. (2008) Micropatterning for quantitative analysis of protein-protein interactions in living cells. Nat Methods 5: 1053-1060.
22. Sunzenauer S, Zojer V, Brameshuber M, Trols A, Weghuber J, et al. (2013) Determination of binding curves via protein micropatterning in vitro and in living cells. Cytometry A 83: 847-854.
23. Weghuber J, Brameshuber M, Sunzenauer S, Lehner M, Paar C, et al. (2010) Detection of protein-protein interactions in the live cell plasma membrane by quantifying prey redistribution upon bait micropatterning. Methods Enzymol 472: 133-151.
24. Weghuber J, Sunzenauer S, Brameshuber M, Plochberger B, Hesch C, et al. (2010) in-vivo detection of protein-protein interactions on micro-patterned surfaces. J Vis Exp.
25. Weghuber J, Sunzenauer S, Plochberger B, Brameshuber M, Haselgrubler T, et al. (2010) Temporal resolution of protein-protein interactions in the live-cell plasma membrane. Anal Bioanal Chem 397: 3339-3347.
26. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, et al. (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 431-442.
27. Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
28. Borgmann DM, Weghuber J, Schaller S, Jacak J, Winkler SM (2012) Identification of Patterns in Microscopy Images of Biological Samples Using Evolution Strategies. Proceedings of the 24th European Modeling and Simulation Symposium.
29. Schulze WX, Deng L, Mann M (2005) Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol 1: 2005 0008.
30. Yamazaki T, Zaal K, Hailey D, Presley J, Lippincott-Schwartz J, et al. (2002) Role of Grb2 in EGF-stimulated EGFR internalization. J Cell Sci 115: 1791-1802. (Pubitemid 34567241)
31. Ferraro DA, Gaborit N, Maron R, Cohen-Dvashi H, Porat Z, et al. (2013) Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR. Proc Natl Acad Sci U S A 110: 1815-1820.
32. Giocanti N, Hennequin C, Rouillard D, Defrance R, Favaudon V (2004) Additive interaction of gefitinib ('Iressa', ZD1839) and ionising radiation in human tumour cells in vitro. Br J Cancer 91: 2026-2033. (Pubitemid 40128769)
33. Narayanan R, Kim HN, Narayanan NK, Nargi D, Narayanan B (2012) Epidermal growth factor-stimulated human cervical cancer cell growth is associated with EGFR and cyclin D1 activation, independent of COX-2 expression levels. Int J Oncol 40: 13-20.
34. Goh LK, Huang F, Kim W, Gygi S, Sorkin A (2010) Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor. J Cell Biol 189: 871-883.
35. Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, et al. (2008) Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell 15: 209-219.
36. Sorkin A, Goh LK (2009) Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 315: 683-696.
37. Jiang X, Huang F, Marusyk A, Sorkin A (2003) Grb2 regulates internalization of EGF receptors through clathrin-coated pits. Mol Biol Cell 14: 858-870. (Pubitemid 36337438)
38. Orth JD, Krueger EW, Weller SG, McNiven MA (2006) A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. Cancer Res 66: 3603-3610.
39. Sorkina T, Huang F, Beguinot L, Sorkin A (2002) Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor. J Biol Chem 277: 27433-27441. (Pubitemid 34951764)
40. Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19: 183-232.
41. Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 7 Suppl 4: 31-39.
42. Batzer AG, Rotin D, Urena JM, Skolnik EY, Schlessinger J (1994) Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol Cell Biol 14: 5192-5201.
43. Chen M, Zaytseva NV, Wu Q, Li M, Fang Y (2013) Microplate-compatible total internal reflection fluorescence microscopy for receptor pharmacology. Applied Physics Letters 102.
44. Fortian A, Sorkin A (2013) Live cell fluorescence imaging reveals high stoichiometry of Grb2 binding to the EGF receptor sustained during endocytosis. J Cell Sci.
45. Oh D, Ogiue-Ikeda M, Jadwin JA, Machida K, Mayer BJ, et al. (2012) Fast rebinding increases dwell time of Src homology 2 (SH2)-containing proteins near the plasma membrane. Proc Natl Acad Sci U S A 109: 14024-14029.
46. Morimatsu M, Takagi H, Ota KG, Iwamoto R, Yanagida T, et al. (2007) Multiple-state reactions between the epidermal growth factor receptor and Grb2 as observed by using single-molecule analysis. Proc Natl Acad Sci U S A 104: 18013-18018. (Pubitemid 350210812)
47. Heukers R, Vermeulen JF, Fereidouni F, Bader AN, Voortman J, et al. (2013) EGFR endocytosis requires its kinase activity and N-terminal transmembrane dimerization motif. J Cell Sci.